EFPIA’s new paper, “List of Proposals to Support Clinical Trials in Europe,” presents a comprehensive set of recommendations aimed at making the EU a more attractive and efficient location for clinical research. With input from members across the pharmaceutical sector, the paper identifies practical ways to streamline processes, reduce delays, and foster innovation — all with the goal of improving patient access to cutting-edge treatments.

At a time when Europe is striving to remain competitive in global clinical research, this proposal list underscores the importance of regulatory agility, digital infrastructure, and public-private cooperation. The document offers actionable steps for policymakers and stakeholders to create a future-ready clinical trial landscape.